Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
25,297
Sort by:
Superdisintegrants Market Size, Share and Growth Outlook 2026: By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin, Natural Superdisintegrants), By Formulation, By Therapeutic Area, By End User, Companies to 2034.
US$ 3,482.00
The global Superdisintegrants Market size is forecast to increase from $619.49 Million in 2026 to $957.96 Million in 2034 at a CAGR of 5.6% between 2026 and 2034. The Superdisintegrants market report...
July 2026
190 pages
Sustained Release Excipients Market Size, Share and Growth Outlook 2026: By Product (Polymers, Gelatin, Minerals, Sugars, Alcohol, Chitosan), By Technology, By Route of Administration, By Application, Companies to 2034.
US$ 3,482.00
The global Sustained Release Excipients Market size is forecast to increase from $1.81 Billion in 2026 to $3.42 Billion in 2034 at a CAGR of 8.28% between 2026 and 2034. The Sustained Release Excipien...
July 2026
190 pages
Immuno-oncology Clinical Trials Market Size, Share and Growth Outlook 2026: By Therapy Type (Checkpoint Inhibitors, CAR-T Cell Therapies, Monoclonal Antibodies, Cancer Vaccines, Cytokines), By Cancer Type, By Phase, By End-User, Companies to 2034.
US$ 3,482.00
The global Immuno-oncology Clinical Trials Market size is forecast to increase from $11.29 Billion in 2026 to $28.76 Billion in 2034 at a CAGR of 12.4% between 2026 and 2034. The Immuno-oncology Clini...
July 2026
190 pages
Microbial API Market Size, Share and Growth Outlook 2026: By Type (Antibiotics, Amino Acids, Vitamins, Nucleotides, Organic Acids, Biological Products, Hormones), By Application, By Manufacturing Site, Companies to 2034.
US$ 3,482.00
The global Microbial API Market size is forecast to increase from $70.01 Billion in 2026 to $118.86 Billion in 2034 at a CAGR of 6.84% between 2026 and 2034. The Microbial API market report provides d...
July 2026
190 pages
Morphine Drugs Market Size, Share and Growth Outlook 2026: By Drug (Morphine, Buprenorphine, Noscapin, Thebaine, Etrophine), By Dosage Form, By Application, By Distribution Channel, By End-User, Companies to 2034.
US$ 3,482.00
The global Morphine Drugs Market size is forecast to increase from $26.93 Billion in 2026 to $39.4 Billion in 2034 at a CAGR of 4.87% between 2026 and 2034. The Morphine Drugs market report provides d...
July 2026
190 pages
Oncology Clinical Trials Market Size, Share and Growth Outlook 2026: By Phase Type (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Cancer Type, By Therapy Type, By End-User, Companies to 2034.
US$ 3,482.00
The global Oncology Clinical Trials Market size is forecast to increase from $39.62 Billion in 2026 to $72.47 Billion in 2034 at a CAGR of 7.84% between 2026 and 2034. The Oncology Clinical Trials mar...
July 2026
190 pages
